AR882 Dose 2

DRUG2 trials

Sponsors

Arthrosi Therapeutics

Conditions

Arthritis, GoutyGoutGout ChronicHyperuricemia

Phase 2

Phase 2b Evaluation of Efficacy and Safety of AR882 in Gout Patients

CompletedNCT05119686

Arthrosi TherapeuticsArthritis, Gouty, Gout, Gout Chronic +1

Start: 2021-11-16End: 2022-11-17Updated: 2023-05-12

Phase 2 to Assess Efficacy and Safety in AR882 Alone or in Combination With Allopurinol in Patients With Tophaceous Gout

CompletedNCT05253833

Arthrosi TherapeuticsArthritis, Gouty, Gout, Gout Chronic +1

Start: 2022-08-12End: 2024-10-28Updated: 2025-01-29